Fracture risk and bone mineral density in Turner syndrome

Reviews in Endocrine and Metabolic Disorders

Volumn 9, Issue 2, 2008, Pages 145-151

  Bakalov, Vladimir K ^a   Bondy, Carolyn A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Bone mineral density; Fracture risk; Hormone replacement therapy; Turner syndrome

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; ESTRADIOL; ESTROGEN; GLUCOCORTICOID; HUMAN GROWTH HORMONE; PLACEBO; VITAMIN D;

BONE DENSITY; BONE INJURY; CLINICAL TRIAL; CONTACT SPORT; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE; FALLING; FRACTURE; GEOMETRY; HORMONE SUBSTITUTION; HUMAN; KARYOTYPE; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; RECOMMENDED DRUG DOSE; REVIEW; RISK ASSESSMENT; RISK FACTOR; TURNER SYNDROME;

BONE DENSITY; FRACTURES, BONE; HORMONE REPLACEMENT THERAPY; HUMANS; RISK FACTORS; TURNER SYNDROME;

EID: 42549107387     PISSN: 13899155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11154-008-9076-2     Document Type: Review

References (50)

1. Turner HH. A syndrome of infantilism, congenital webbed neck, and cubitus valgus. Endocrinology. 1938;23:566-74.
2. Shore RM, Chesney RW, Mazess RB, Rose PG, Bargman GJ. Skeletal demineralization in Turner's syndrome. Calcif Tissue Int. 1982;34(6):519-22.
3. Smith MA, Wilson J, Price WH. Bone demineralisation in patients with Turner's syndrome. J Med Genet. 1982;19(2):100-3.
4. Gravholt CH, Juul S, Naeraa RW, Hansen J. Morbidity in Turner syndrome. J Clin Epidemiol. 1998;51(2):147-58.
5. Gravholt CH, Vestergaard P, Hermann AP, Mosekilde L, Brixen K, Christiansen JS. Increased fracture rates in Turner's syndrome: a nationwide questionnaire survey. Clin Endocrinol (Oxf). 2003;59(1):89-96.
6. Landin-Wilhelmsen K, Bryman I, Windh M, Wilhelmsen L. Osteoporosis and fractures in Turner syndrome-importance of growth promoting and oestrogen therapy. Clin Endocrinol (Oxf). 1999;51(4):497-502.
7. Bakalov VK, Axelrod L, Baron J, et al. Selective reduction in cortical bone mineral density in turner syndrome independent of ovarian hormone deficiency. J Clin Endocrinol Metab. 2003;88(12):5717-22.
8. Gravholt CH, Lauridsen AL, Brixen K, Mosekilde L, Heickendorff L, Christiansen JS. Marked disproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult turner syndrome: a cross-sectional study. J Clin Endocrinol Metab. 2002;87(6):2798-808.
9. Hogler W, Briody J, Moore B, Garnett S, Lu PW, Cowell CT. Importance of estrogen on bone health in Turner syndrome: a cross-sectional and longitudinal study using dual-energy X-ray absorptiometry. J Clin Endocrinol Metab. 2004;89(1):193-9.
10. Lanes R, Gunczler P, Esaa S, Martinis R, Villaroel O, Weisinger JR. Decreased bone mass despite long-term estrogen replacement therapy in young women with Turner's syndrome and previously normal bone density. Fertil Steril. 1999;72(5):896-9.
11. Bakalov VK, Chen ML, Baron J, et al. Bone mineral density and fractures in Turner syndrome. Am J Med. 2003;115(4):259-64.
12. Neely EK, Marcus R, Rosenfeld RG, Bachrach LK. Turner syndrome adolescents receiving growth hormone are not osteopenic. J Clin Endocrinol Metab. 1993;76(4):861-6.
13. Ross JL, Long LM, Feuillan P, Cassorla F, Cutler GB Jr. Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner's syndrome. J Clin Endocrinol Metab. 1991;73(2):355-9.
14. Han TS, Cadge B, Conway GS. Hearing impairment and low bone mineral density increase the risk of bone fractures in women with Turner's syndrome. Clin Endocrinol (Oxf). 2006;65(5):643-7.
15. Garden AS, Diver MJ, Fraser WD. Undiagnosed morbidity in adult women with Turner's syndrome. Clin Endocrinol (Oxf). 1996;45(5):589-93.
16. Zuckerman-Levin N, Yaniv I, Schwartz T, Guttmann H, Hochberg Z. Normal DXA bone mineral density but frail cortical bone in Turner's syndrome. Clin Endocrinol. 2007;67:60-4.
17. Davies MC, Gulekli B, Jacobs HS. Osteoporosis in Turner's syndrome and other forms of primary amenorrhoea. Clin Endocrinol (Oxf). 1995;43(6):741-6.
18. Ross JL, Scott C Jr., Marttila P, et al. Phenotypes Associated with SHOX Deficiency. J Clin Endocrinol Metab. 2001;86(12):5674-80.
19. Bakalov VK, Van PL, Baron J, Reynolds JC, Bondy CA. Growth hormone therapy and bone mineral density in Turner syndrome. J Clin Endocrinol Metab. 2004;89(10):4886-9.
20. El-Mansoury M, Barrenas ML, Bryman I, et al. Chromosomal mosaicism mitigates stigmata and cardiovascular risk factors in Turner syndrome. Clin Endocrinol (Oxf). 2007;66(5):744-51.
21. Nissen N, Gravholt CH, Abrahamsen B, et al. Disproportional geometry of the proximal femur in patients with Turner syndrome: a cross-sectional study. Clin Endocrinol (Oxf) 2007;67(6):987-03.
22. Ensrud KE, Lipschutz RC, Cauley JA, et al. Body size and hip fracture risk in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Am J Med. 1997;103(4):274-80.
23. Faulkner KG, Cummings SR, Black D, Palermo L, Gluer CC, Genant HK. Simple measurement of femoral geometry predicts hip fracture: the study of osteoporotic fractures. J Bone Miner Res. 1993;8(10):1211-7.
24. Gnudi S, Ripamonti C, Gualtieri G, Malavolta N. Geometry of proximal femur in the prediction of hip fracture in osteoporotic women. Br J Radiol. 1999;72(860):729-33.
25. Alonso CG, Curiel MD, Carranza FH, Cano RP, Perez AD. Femoral bone mineral density, neck-shaft angle and mean femoral neck width as predictors of hip fracture in men and women. Multicenter Project for Research in Osteoporosis. Osteoporos Int. 2000;11(8):714-20.
26. Gnudi S, Malavolta N, Testi D, Viceconti M. Differences in proximal femur geometry distinguish vertebral from femoral neck fractures in osteoporotic women. Br J Radiol. 2004;77(915):219-23.
27. Nijhuis-van der Sanden MW, Eling PA, Otten BJ. A review of neuropsychological and motor studies in Turner Syndrome. Neurosci Biobehav Rev. 2003;27(4):329-38.
28. Ross JL, Kowal K, Quigley CA, et al. The phenotype of short stature homeobox gene (SHOX) deficiency in childhood: contrasting children with Leri-Weill dyschondrosteosis and Turner syndrome. J Pediatr. 2005;147(4):499-507.
29. Bechtold S, Rauch F, Noelle V, et al. Musculoskeletal analyses of the forearm in young women with Turner syndrome: a study using peripheral quantitative computed tomography. J Clin Endocrinol Metab. 2001;86(12):5819-23.
30. Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, et al. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study. Pediatr Res. 2001;50(3):417-22.
31. Schoenau E, Neu CM, Rauch F, Manz F. Gender-specific pubertal changes in volumetric cortical bone mineral density at the proximal radius. Bone. 2002;31(1):110-3.
32. Neu CM, Rauch F, Manz F, Schoenau E. Modeling of cross-sectional bone size, mass and geometry at the proximal radius: a study of normal bone development using peripheral quantitative computed tomography. Osteoporos Int. 2001;12(7):538-47.
33. Ma D, Jones G. The association between bone mineral density, metacarpal morphometry, and upper limb fractures in children: a population-based case-control study. J Clin Endocrinol Metab. 2003;88(4):1486-91.
34. Hanton L, Axelrod L, Bakalov V, Bondy CA. The importance of estrogen replacement in young women with Turner syndrome. J Womens Health (Larchmt). 2003;12(10):971-7.
35. Khastgir G, Studd JW, Fox SW, Jones J, Alaghband-Zadeh J, Chow JW. A longitudinal study of the effect of subcutaneous estrogen replacement on bone in young women with Turner's syndrome. J Bone Miner Res. 2003;18(5):925-32.
36. Stepan JJ, Musilova J, Pacovsky V. Bone demineralization, biochemical indices of bone remodeling, and estrogen replacement therapy in adults with Turner's syndrome. J Bone Miner Res. 1989;4(2):193-8.
37. Pors Nielsen S, Kolthoff N, Barenholdt O, et al. Diagnosis of osteoporosis by planar bone densitometry: can body size be disregarded? Br J Radiol. 1998;71(849):934-43.
38. Genant HK, Block JE, Steiger P, Glueer CC, Smith R. Quantitative computed tomography in assessment of osteoporosis. Semin Nucl Med. 1987;17(4):316-33.
39. Augat P, Gordon CL, Lang TF, Iida H, Genant HK. Accuracy of cortical and trabecular bone measurements with peripheral quantitative computed tomography (pQCT). Phys Med Biol. 1998;43(10):2873-83.
40. Carter DR, Bouxsein ML, Marcus R. New approaches for interpreting projected bone densitometry data. J Bone Miner Res. 1992;7(2):137-45.
41. Jergas M, Breitenseher M, Gluer CC, Yu W, Genant HK. Estimates of volumetric bone density from projectional measurements improve the discriminatory capability of dual X-ray absorptiometry. J Bone Miner Res. 1995;10(7):1101-10.
42. Naeraa RW, Brixen K, Hansen RM, et al. Skeletal size and bone mineral content in Turner's syndrome: relation to karyotype, estrogen treatment, physical fitness, and bone turnover. Calcif Tissue Int. 1991;49(2):77-83.
43. Saggese G, Baroncelli GI, Bertelloni S, Barsanti S. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass. J Clin Endocrinol Metab. 1996;81(8):3077-83.
44. Sass TC, De Muinck Keizer-Schrama SM, Stijnen T, et al. A longitudinal study on bone mineral density until adulthood in girls with Turner's syndrome participating in a growth hormone injection frequency-response trial. Clin Endocrinol (Oxf). 2000;52(5):531-6.
45. Suganuma N, Furuhashi M, Hirooka T, et al. Bone mineral density in adult patients with Turner's syndrome: analyses of the effectiveness of GH and ovarian steroid hormone replacement therapies. Endocr J. 2003;50(3):263-9.
46. Sato N, Nimura A, Horikawa R, Katumata N, Tanae A, Tanaka T. Bone mineral density in Turner syndrome: relation to GH treatment and estrogen treatment. Endocr J. 2000;47(Suppl):S115-9.
47. Rubin K. Turner syndrome and osteoporosis: mechanisms and prognosis. Pediatrics. 1998;102(2 Pt 3):481-5.
48. Rubin K. Transitioning the patient with Turner's syndrome from pediatric to adult care. J Pediatr Endocrinol Metab. 2003;16(Suppl 3):651-9.
49. Saenger P. Turner's syndrome. N Engl J Med. 1996;335(23):1749-54.
50. Saenger P, Wikland KA, Conway GS, et al. Recommendations for the diagnosis and management of Turner syndrome. J Clin Endocrinol Metab. 2001;86(7):3061-9.